CN102406762A - Chinese medicinal preparation for treating chronic prostatitis - Google Patents
Chinese medicinal preparation for treating chronic prostatitis Download PDFInfo
- Publication number
- CN102406762A CN102406762A CN2011103841397A CN201110384139A CN102406762A CN 102406762 A CN102406762 A CN 102406762A CN 2011103841397 A CN2011103841397 A CN 2011103841397A CN 201110384139 A CN201110384139 A CN 201110384139A CN 102406762 A CN102406762 A CN 102406762A
- Authority
- CN
- China
- Prior art keywords
- parts
- chronic prostatitis
- medicinal preparation
- chinese medicinal
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal preparation for treating the chronic prostatitis. The traditional Chinese medical science considers that the chronic prostatitis has the main pathogenic factors of dampness and heat, extravasated blood and lier constraint and always has deficiency complicated with excess and sthenia. The traditional Chinese medicine has the treatment principles of clearing heat and removing turbidness and soothing the liver and removing blood stasis. Therefore, in the invention, astragalus, safflower, lumbricus, red paeony root, ligusticum wallichii, prunella vulgaris, kelp, indigowoad leaf and dandelion dahurian angelicaroot are selected to be prepared into decoction; after the decoction is orally administrated to a patient, a good treatment effect is obtained; by clinical tests, the total effective rate of the Chinese medicinal preparation reaches 91.1 percent and is obviously higher than that of the control group; and the Chinese medicinal preparation has no adverse effect and is valuable to be clinically popularized and applied.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine preparation of treating chronic prostatitis.
Background technology
Chronic prostatitis is the commonly encountered diseases and the frequently-occurring disease of male genitourinary system, almost accounts for the first place of andrology's outpatient service.Because of primary disease treatment time longer, curative effect is lower, easily repeatedly with cause sexual dysfunction, patient often psychological burden is heavy, the very easy outbreak repeatedly that increases the weight of primary disease.Though modern age antibacterials continuous development, because the barrier action of prostatic epithelium, antibiotic is difficult to bring into play direct therapeutical effect through the prostate barrier, therapeutic effect is not satisfactory.
At present, though the Chinese and western drugs of treatment chronic prostatitis is a lot, all exist therapeutic effect poor, side effect is big, the problem that relapse rate is high.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine preparation of treating chronic prostatitis.The traditional Chinese medical science thinks, damp and hot, congestion, stagnation of liver-QI then are the main pathological factors of primary disease, and are mostly the card of simulataneous insufficiency and excessive.For this reason, the traditional Chinese medical science should be turbid with the heat clearing away profit, the soothing liver-QI silt is the Therapeutic Principle.
The objective of the invention is to realize that through following technical scheme the Chinese medicine preparation of this treatment chronic prostatitis is processed by following parts by weight of Chinese traditional medicine: Radix Astragali 7-13 part, Flos Carthami 5-10 part, Pheretima 7-13 part, Radix Paeoniae Rubra 15-20 part, Rhizoma Chuanxiong 10-15 part, Spica Prunellae 5-9 part, Thallus Laminariae (Thallus Eckloniae) 7-13 part, Folium Isatidis 10-15 part, Herba Taraxaci 7-13 part, Radix Angelicae Dahuricae 5-10 part, Radix Bupleuri 10-15 part.
Preferably, the Chinese medicine preparation of this treatment chronic prostatitis is processed by following parts by weight of Chinese traditional medicine: 10 parts of the Radixs Astragali, 7 parts on Flos Carthami, 10 parts of Pheretimas, 17 parts of Radix Paeoniae Rubra, 12 parts of Rhizoma Chuanxiongs, 7 parts of Spica Prunellaes, 10 parts of Thallus Laminariae (Thallus Eckloniae)s, 12 parts of Folium Isatidiss, 10 parts of Herba Taraxacis, 7 parts of the Radixs Angelicae Dahuricae, 13 parts of Radix Bupleuri.
Processing decoction according to traditional decocting method takes.
The Radix Astragali, Flos Carthami, Pheretima tonification vigour, removing blood stasis collateral dredging are monarch in the side, join Radix Paeoniae Rubra, Rhizoma Chuanxiong, Spica Prunellae, Thallus Laminariae (Thallus Eckloniae) with blood circulation promoting and blood stasis dispelling, hard masses softening and resolving; Folium Isatidis, Herba Taraxaci, the Radix Angelicae Dahuricae can heat-clearing and toxic substances removing, again can the dampness removing collateral dredging; Radix Bupleuri is evacuated and is brought down a fever the yang invigorating soothing liver-QI.All medicines share, and play the merit of disperse blood stasis and dredge collateral, heat-clearing and toxic substances removing kidney tonifying altogether.
Clinical data
1, physical data
Selected 112 examples are year February in August, 2006 to 2009 my institute and go to a doctor and make a definite diagnosis patients with chronic prostatitis.Be divided into two groups at random.Wherein 56 examples are organized in treatment, minimum 21 years old of age, maximum 64 years old, average 36 years old; The course of disease the shortest May, the longest 6 years, average 1.9 years.Matched group 56 examples, minimum 20 years old of age, maximum 63 years old, average 35.5 years old; The course of disease is the shortest 4.5 months, and is the longest 5.5 years, average 1.8 years.Physical data such as two groups of case sexes, age, the course of disease have comparability through statistical procedures there was no significant difference (P>0.05).
2, diagnostic criteria
Clinical symptoms: frequent micturition, dysurea is urinated smooth or burn feeling is arranged; Dribble of urine not to the utmost; Urinate eventually the end or when firmly defecating urethral orifice the white phenomenon of dripping is arranged, morning, the time-out urethral orifice had sticky discharge, lumbosacral region, perineal position, lower abdomen, groin, testis or spermatic cord, glans penis pain; Sexual hypofunction or with sterile, or insomnia and dreamful sleep, stomachache, weak etc. are arranged.Digital rectal examination: prostate size is normal, or slightly increase, tenderness, surperficial soft or hard is inhomogeneous maybe can touch tuberosity.Prostatic fluid (EPS) inspection: leukocyte>10/HP, lecithin reduces.
3, Therapeutic Method
The treatment group is taken the Chinese medicine preparation of the chronic preceding adenitis of treatment of the present invention; Promptly get Radix Astragali 10g, Flos Carthami 7g, Pheretima 10g, Radix Paeoniae Rubra 17g, Rhizoma Chuanxiong 12g, Spica Prunellae 7g, Thallus Laminariae (Thallus Eckloniae) 10g, Folium Isatidis 12g, Herba Taraxaci 10g, Radix Angelicae Dahuricae 7g, Radix Bupleuri 13g; Add water 500mL, steep 20min earlier, intense fire boils 30min; Get liquid 200mL, divide every day secondary oral.
Matched group is taken QIANLIEKANG PIAN, 1 time 2,3 times on the 1st, oral.30 days is 1 course of treatment, period in a medicine other antagonism cooperative drug of stopping using.
4, criterion of therapeutical effect
The basic healing: subjective symptoms disappears, and the prostate glandular hyperplasia is stablized or dwindled, no frequent micturition, and urgent micturition, the soreness of waist, the prostatic fluid chemical examination is normal, and above each item index was stablized more than 1 year; Effectively: cardinal symptom disappears or basic the disappearance, and prostatic hyperplasia is stablized constant, and does not have tangible frequent micturition, urgent micturition, and the normal or lecithin of examination of prostatic fluid increases more than 50%, and red, leukopenia is more than 50%, and continues 3 months; Invalid: after finishing the course of treatment, symptom does not have obvious improvement, and prostate inflammatory hypertrophy does not have improvement.
5, therapeutic outcome
Two groups of curative effects compare: add up after treating a course of treatment, 56 examples are organized in treatment, wherein cure 22 examples (39.3%), effective 29 examples (51.8%), and invalid 5 examples (8.90%), total effective rate is 91.1%; Matched group 56 examples are wherein cured 15 examples (26.8%), effective 28 examples (50.0%), and invalid 13 examples (23.2%), total effective rate is 76.8%.
Two groups of total effective rates relatively have significant difference (P<0.01), explain that the curative effect of treatment group obviously is superior to matched group.
Aspect clinical symptoms improved, wherein frequent micturition, urgent micturition, dysurea treatment group curative effect were superior to matched group; Aspect elimination local symptom (perineal position discomfort/dull pain), the treatment group also significantly is superior to matched group; But improving stomachache, soreness of waist aspect, two groups of equal and good results compare there was no significant difference between group.
Clinical observation untoward reaction all do not occur for two groups.
The specific embodiment
Embodiment one: take by weighing Radix Astragali 10g, Flos Carthami 7g, Pheretima 10g, Radix Paeoniae Rubra 17g, Rhizoma Chuanxiong 12g, Spica Prunellae 7g, Thallus Laminariae (Thallus Eckloniae) 10g, Folium Isatidis 12g, Herba Taraxaci 10g, Radix Angelicae Dahuricae 7g, Radix Bupleuri 13g; Add water 500mL, steep 20min earlier, intense fire boils 30min; Get liquid 200mL, divide every day secondary oral.
Embodiment two: take by weighing Radix Astragali 13g, Flos Carthami 5g, Pheretima 7g, Radix Paeoniae Rubra 15g, Rhizoma Chuanxiong 15g, Spica Prunellae 9g, Thallus Laminariae (Thallus Eckloniae) 7g, Folium Isatidis 15g, Herba Taraxaci 7g, Radix Angelicae Dahuricae 5g, Radix Bupleuri 15g; Add water 500mL, steep 20min earlier, intense fire boils 30min; Get liquid 200mL, divide every day secondary oral.
Embodiment three: take by weighing Radix Astragali 7g, Flos Carthami 10g, Pheretima 13g, Radix Paeoniae Rubra 20g, Rhizoma Chuanxiong 10g, Spica Prunellae 5g, Thallus Laminariae (Thallus Eckloniae) 13g, Folium Isatidis 10g, Herba Taraxaci 13g, Radix Angelicae Dahuricae 10g, Radix Bupleuri 10g; Add water 500mL, steep 20min earlier, intense fire boils 30min; Get liquid 200mL, divide every day secondary oral.
Claims (2)
1. a Chinese medicine preparation of treating chronic prostatitis is characterized in that the Chinese medicine preparation of this treatment chronic prostatitis is processed by following parts by weight of Chinese traditional medicine: Radix Astragali 7-13 part, Flos Carthami 5-10 part, Pheretima 7-13 part, Radix Paeoniae Rubra 15-20 part, Rhizoma Chuanxiong 10-15 part, Spica Prunellae 5-9 part, Thallus Laminariae (Thallus Eckloniae) 7-13 part, Folium Isatidis 10-15 part, Herba Taraxaci 7-13 part, Radix Angelicae Dahuricae 5-10 part, Radix Bupleuri 10-15 part.
2. a kind of Chinese medicine preparation of treating chronic prostatitis according to claim 1 is characterized in that the Chinese medicine preparation of this treatment chronic prostatitis is processed by following parts by weight of Chinese traditional medicine: 10 parts of the Radixs Astragali, 7 parts on Flos Carthami, 10 parts of Pheretimas, 17 parts of Radix Paeoniae Rubra, 12 parts of Rhizoma Chuanxiongs, 7 parts of Spica Prunellaes, 10 parts of Thallus Laminariae (Thallus Eckloniae)s, 12 parts of Folium Isatidiss, 10 parts of Herba Taraxacis, 7 parts of the Radixs Angelicae Dahuricae, 13 parts of Radix Bupleuri.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103841397A CN102406762B (en) | 2011-11-18 | 2011-11-18 | Chinese medicinal preparation for treating chronic prostatitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011103841397A CN102406762B (en) | 2011-11-18 | 2011-11-18 | Chinese medicinal preparation for treating chronic prostatitis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102406762A true CN102406762A (en) | 2012-04-11 |
CN102406762B CN102406762B (en) | 2013-02-20 |
Family
ID=45909299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011103841397A Expired - Fee Related CN102406762B (en) | 2011-11-18 | 2011-11-18 | Chinese medicinal preparation for treating chronic prostatitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102406762B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1444987A (en) * | 2003-04-24 | 2003-10-01 | 陈子华 | Compound preparation of Chinese herbal medicine for treating chronic prostatitis and its preparing method |
CN1911344A (en) * | 2006-08-14 | 2007-02-14 | 黄南锡 | Hip bath medicine for treating chronic prostatitis, and its prepn. method |
-
2011
- 2011-11-18 CN CN2011103841397A patent/CN102406762B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1444987A (en) * | 2003-04-24 | 2003-10-01 | 陈子华 | Compound preparation of Chinese herbal medicine for treating chronic prostatitis and its preparing method |
CN1911344A (en) * | 2006-08-14 | 2007-02-14 | 黄南锡 | Hip bath medicine for treating chronic prostatitis, and its prepn. method |
Also Published As
Publication number | Publication date |
---|---|
CN102406762B (en) | 2013-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102370725B (en) | A kind of compound Chinese medicinal preparation treating chronic pelvic inflammatory disease and preparation method thereof | |
CN102178800B (en) | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
CN102228603B (en) | Chinese medicine for treating retention of urine | |
CN101040927B (en) | Chinese traditional medicine compound took orally for treating ankylosing spondylitis | |
CN101785810B (en) | Traditional Chinese medicine preparation for anaphylactoid purpura treatment | |
CN103830527B (en) | One treats prostatitic preparation | |
CN102210753A (en) | Traditional Chinese medicine composition for treating lithiasis in urinary system | |
CN103285263A (en) | Medicine for treating psoriasis vulgaris | |
CN101002848B (en) | Medicine for treating recurrent uarthritis, and its preparing method | |
CN104547117A (en) | Traditional Chinese medicine preparation for treating gonarthromeningitis | |
CN104001146A (en) | Traditional Chinese medicine composition for curing dysmenorrhea | |
CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
CN102406762B (en) | Chinese medicinal preparation for treating chronic prostatitis | |
CN103386055B (en) | Qianlieantong capsule and preparation method thereof | |
CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
CN104013704A (en) | Pharmaceutical composition for treating chronic pelvic inflammatory disease and preparation method of composition | |
CN103611027A (en) | Pharmaceutical composition for clinically preventing, nursing and treating trichomonas vaginitis | |
CN102228643A (en) | Traditional Chinese medicine composition for treating chronic prostatitis | |
CN103520638B (en) | A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof | |
CN102240384B (en) | Medicament for treating phlegm-stasis accumulating type epilepsy and preparation method thereof | |
CN101732624A (en) | Formula for treating ureteral calculi and preparation method thereof | |
CN105688096A (en) | Traditional Chinese medicine composition for treating gout | |
CN105168881A (en) | Traditional Chinese medicinal composition for treating stages I and II of chronic renal failure | |
CN103446558B (en) | A kind of Chinese medicine for the treatment of chronic nephritis | |
CN104257898A (en) | Traditional Chinese medicine preparation for treating irregular postpartum menstruation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130220 Termination date: 20131118 |